新生儿期的抗逆转录病毒疗法。 - Suppr

Suppr

超能文献

Antiretroviral therapy during the neonatal period.

作者信息

Nuttall James J C

机构信息

Red Cross War Memorial Children's Hospital, Cape Town, South Africa.

Department of Paediatrics and Child Health, University of Cape Town, South Africa.

出版信息

South Afr J HIV Med. 2015 May 4;16(1):361. doi: 10.4102/sajhivmed.v16i1.361. eCollection 2015.

DOI:10.4102/sajhivmed.v16i1.361

PMID:29568586

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5843175/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ea6/5843175/98d32f0aa208/HIVMED-16-361-g001.jpg

相似文献

Antiretroviral therapy during the neonatal period.

South Afr J HIV Med. 2015 May 4;16(1):361. doi: 10.4102/sajhivmed.v16i1.361. eCollection 2015.

Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.

Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):425-36.

Antiretroviral therapy and mother-to-child transmission of HIV-1.

Expert Rev Anti Infect Ther. 2004 Oct;2(5):717-32. doi: 10.1586/14789072.2.5.717.

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Pediatrics. 2007 Apr;119(4):e900-6. doi: 10.1542/peds.2006-1123. Epub 2007 Mar 12.

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.

JAMA. 2000 Jul 12;284(2):190-7. doi: 10.1001/jama.284.2.190.

Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.

Reprod Health. 2018 May 10;15(1):76. doi: 10.1186/s12978-018-0513-8.

Prevention of perinatal HIV transmission: current status and future developments in anti-retroviral therapy.

Drugs. 2002;62(15):2213-20. doi: 10.2165/00003495-200262150-00004.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Cochrane Database Syst Rev. 2002(2):CD003510. doi: 10.1002/14651858.CD003510.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Cochrane Database Syst Rev. 2002(1):CD003510. doi: 10.1002/14651858.CD003510.

A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.

Pediatrics. 2006 Oct;118(4):e1139-45. doi: 10.1542/peds.2006-0525. Epub 2006 Aug 28.

引用本文的文献

Population pharmacokinetic modeling of paired plasma-breast milk lamivudine data for estimation of infant exposure in breastfeeding mother-infant pairs.

CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1978-1989. doi: 10.1002/psp4.13274. Epub 2024 Nov 7.

Post-Natal Anti-Retroviral Prophylaxis for Neonates Born to Mothers Living with Resistant HIV Infection.

Sultan Qaboos Univ Med J. 2023 Aug;23(3):405-410. doi: 10.18295/squmj.5.2022.039. Epub 2023 Aug 28.

Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?

Front Microbiol. 2020 Jan 31;11:46. doi: 10.3389/fmicb.2020.00046. eCollection 2020.

HIV testing and antiretroviral therapy initiation at birth: Views from a primary care setting in Khayelitsha.

South Afr J HIV Med. 2015 Apr 28;16(1):376. doi: 10.4102/sajhivmed.v16i1.376. eCollection 2015.

Research gaps in neonatal HIV-related care.

South Afr J HIV Med. 2015 May 20;16(1):375. doi: 10.4102/sajhivmed.v16i1.375. eCollection 2015.

本文引用的文献

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?

J Int AIDS Soc. 2014 Jun 11;17(1):18914. doi: 10.7448/IAS.17.1.18914. eCollection 2014.

Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.

AIDS. 2014 Jul 17;28(11):1673-8. doi: 10.1097/QAD.0000000000000261.

Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years.

Clin Infect Dis. 2014 Feb;58(3):413-22. doi: 10.1093/cid/cit696. Epub 2013 Oct 21.

Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?

AIDS. 2013 Aug 24;27(13):2111-5. doi: 10.1097/QAD.0b013e3283620811.

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Lancet. 2013 Apr 20;381(9875):1391-1403. doi: 10.1016/S0140-6736(12)62198-9. Epub 2013 Mar 7.

Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.

N Engl J Med. 2012 Jun 21;366(25):2380-9. doi: 10.1056/NEJMoa1113249.

Early antiretroviral therapy improves neurodevelopmental outcomes in infants.

AIDS. 2012 Aug 24;26(13):1685-90. doi: 10.1097/QAD.0b013e328355d0ce.

Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age.

AIDS. 2012 Jul 31;26(12):1483-90. doi: 10.1097/QAD.0b013e3283553638.

Trough lopinavir concentrations in preterm HIV-infected infants.

Pediatr Infect Dis J. 2012 Jun;31(6):602-4. doi: 10.1097/INF.0b013e31825046ae.

Developmental pharmacokinetic changes of Lamivudine in infants and children.

J Clin Pharmacol. 2012 Dec;52(12):1824-32. doi: 10.1177/0091270011426563. Epub 2011 Dec 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验